Literature DB >> 2238094

Excitatory amino acid neurotoxicity and neurodegenerative disease.

B Meldrum1, J Garthwaite.   

Abstract

The progress over the last 30 years in defining the role of excitatory amino acids in normal physiological function and in the abnormal neuronal activity of epilepsy has been reviewed in earlier articles in this series. In the last five years it has become clear that excitatory amino acids also play a role in a wide range of neurodegenerative processes. The evidence is clearest where the degenerative process is acute, but is more controversial for slow degenerative processes. In this article Brian Meldrum and John Garthwaite review in vivo and in vitro studies of the cytotoxicity of amino acids and summarize the contribution of such toxicity to acute and chronic neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2238094     DOI: 10.1016/0165-6147(90)90184-a

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  211 in total

1.  Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.

Authors:  M Buttini; M Orth; S Bellosta; H Akeefe; R E Pitas; T Wyss-Coray; L Mucke; R W Mahley
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

Review 2.  Biochemical studies of the structure and function of the N-methyl-D-aspartate subtype of glutamate receptors.

Authors:  A W Dunah; R P Yasuda; J Luo; Y Wang; K L Prybylowski; B B Wolfe
Journal:  Mol Neurobiol       Date:  1999-04       Impact factor: 5.590

3.  Characterization of the binding of two novel glycine site antagonists to cloned NMDA receptors: evidence for two pharmacological classes of antagonists.

Authors:  B Chopra; P L Chazot; F A Stephenson
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

4.  Oxidative glutamate toxicity can be a component of the excitotoxicity cascade.

Authors:  D Schubert; D Piasecki
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

Review 5.  Structural features of the glutamate transporter family.

Authors:  D J Slotboom; W N Konings; J S Lolkema
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

6.  Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneurone disease.

Authors:  B K Vanselow; B U Keller
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

7.  Presynaptic cross-talk of beta-adrenoreceptor and 5-hydroxytryptamine receptor signalling in the modulation of glutamate release from cerebrocortical nerve terminals.

Authors:  Su-Jane Wang; Victoria Coutinho; Talvinder S Sihra
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

8.  Specific [3H]glutamate binding in the cerebral cortex and hippocampus of rats during development: effect of homocysteine-induced seizures.

Authors:  J Folbergrová; V Lisý; R Haugvicová; F Stastný
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

9.  The induction of N-methyl-D-aspartate receptor-dependent long-term potentiation.

Authors:  Graham L Collingridge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-04-29       Impact factor: 6.237

10.  Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme.

Authors:  C J Lowenstein; C S Glatt; D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.